中国医药健康用品批发商及数字医疗综合服务提供商健康160(2656.HK)今日起至周五(9月12日)招股，发售3364.55万股，香港公开发售占10%，其余为国际配售，每股招股价介乎11.89-14.86港元，集资最多5亿港元。一手250股，入场费3752.47港元。该股预期9月17日挂牌。申万宏源香港及清科资本为联席保荐人。 公司拟将所得款项净额中，40%用于进一步扩大医疗资源覆盖面，增加平台流量；30%用于加强集团的研发能力；10%用于丰富产品及服务种类并探索增值服务；10%用于战略合作及收购，对象为健康服务价值链的服务商；及10%用作营运资金及一般企业用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.